Literature DB >> 12735747

Synthesis of a novel conformationally locked carbocyclic nucleoside ring system.

Hak Sung Kim1, Kenneth A Jacobson.   

Abstract

[reaction: see text] A fast and efficient synthetic route to novel Northern locked carbocyclic nucleosides (as precursors of carbocyclic locked nucleic acids or cLNAs) is described. The target nucleoside with a oxabicyclo[2.2.1]heptane ring system was prepared from a simple starting material, diethyl malonate. Ring closure by intramolecular O-alkylation provided the target ring system as the major isomer over the [3.2.0] oxetane system. The adenine moiety was introduced through a reactive triflate after inversion of the stereochemistry of the corresponding alcohol by oxidation and reduction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12735747      PMCID: PMC3153471          DOI: 10.1021/ol034326z

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  9 in total

1.  A simplified and efficient route to 2'-O, 4'-C-methylene-linked bicyclic ribonucleosides (locked nucleic acid).

Authors:  A A Koshkin; J Fensholdt; H M Pfundheller; C Lomholt
Journal:  J Org Chem       Date:  2001-12-14       Impact factor: 4.354

Review 2.  LNA: a versatile tool for therapeutics and genomics.

Authors:  Michael Petersen; Jesper Wengel
Journal:  Trends Biotechnol       Date:  2003-02       Impact factor: 19.536

3.  Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.

Authors:  Hak Sung Kim; R Gnana Ravi; Victor E Marquez; Savitri Maddileti; Anna-Karin Wihlborg; David Erlinge; Malin Malmsjö; José L Boyer; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2002-01-03       Impact factor: 7.446

4.  Construction of the bicyclo[3.1.0]hexane template of a conformationally locked carbocyclic adenosine via an olefin keto-carbene cycloaddition.

Authors:  K J Shin; H R Moon; C George; V E Marquez
Journal:  J Org Chem       Date:  2000-04-07       Impact factor: 4.354

5.  Conformational analysis of the sugar ring in nucleosides and nucleotides. A new description using the concept of pseudorotation.

Authors:  C Altona; M Sundaralingam
Journal:  J Am Chem Soc       Date:  1972-11-15       Impact factor: 15.419

6.  2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist.

Authors:  José L Boyer; Mary Adams; R Gnana Ravi; Kenneth A Jacobson; T Kendall Harden
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

7.  Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA:RNA hybrids.

Authors:  Michael Petersen; Kent Bondensgaard; Jesper Wengel; Jens Peter Jacobsen
Journal:  J Am Chem Soc       Date:  2002-05-29       Impact factor: 15.419

8.  Nucleosides with a twist. Can fixed forms of sugar ring pucker influence biological activity in nucleosides and oligonucleotides?

Authors:  V E Marquez; M A Siddiqui; A Ezzitouni; P Russ; J Wang; R W Wagner; M D Matteucci
Journal:  J Med Chem       Date:  1996-09-13       Impact factor: 7.446

9.  Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.

Authors:  K A Jacobson; X Ji; A H Li; N Melman; M A Siddiqui; K J Shin; V E Marquez; R G Ravi
Journal:  J Med Chem       Date:  2000-06-01       Impact factor: 7.446

  9 in total
  2 in total

1.  A convergent synthesis of carbocyclic sinefungin and its C5 epimer.

Authors:  Arun K Ghosh; Kai Lv
Journal:  European J Org Chem       Date:  2014-10-01

2.  Nucleotide analogues containing 2-oxa-bicyclo[2.2.1]heptane and l-alpha-threofuranosyl ring systems: interactions with P2Y receptors.

Authors:  Michihiro Ohno; Stefano Costanzi; Hak Sung Kim; Veerle Kempeneers; Karen Vastmans; Piet Herdewijn; Savitri Maddileti; Zhan-Guo Gao; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2004-11-01       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.